FDA approves expanded indication for Merck’s Keytruda
Source: ThePharmaLetter, December 2015
The US Food and Drug Administration has approved an expanded indication for Merck’s Keytruda (pembrolizumab)…
In order to access this content you need to be logged into the site and have an active subscription or trial subscription. Please login, take a free trial or subscribe in order to continue reading.